Human Mesenchymal Stem Cells and Their Potential for Treating Stroke
Author Information
Author(s): Nagai Atsushi, Kim Woo K., Lee Hong J., Jeong Han S., Kim Kwang S., Hong Seok H., Park In H., Kim Seung U.
Primary Institution: University of British Columbia
Hypothesis
Can human mesenchymal stem cells (MSCs) derived from fetal marrow differentiate into neural cell types and improve outcomes in a stroke model?
Conclusion
The study found that the B10 human MSC line can differentiate into neurons and astrocytes, and transplantation of these cells into a stroke model improved motor function.
Supporting Evidence
- B10 cells were found to differentiate into neural cell types in vitro.
- B10 cells improved motor function in a mouse model of intracerebral hemorrhage.
- B10 cells produced higher levels of BDNF compared to primary human MSCs.
- Transplanted B10 cells migrated to the site of injury in the brain.
Takeaway
Scientists are studying special cells from human bone marrow that can turn into brain cells and help fix damage from strokes.
Methodology
The study involved isolating and characterizing a stable human MSC line, B10, and testing its differentiation potential and therapeutic effects in a mouse model of intracerebral hemorrhage.
Potential Biases
Potential bias in the interpretation of results due to the lack of long-term follow-up on cell survival and function.
Limitations
The study did not use immunosuppressants, which may have affected the survival of transplanted cells.
Participant Demographics
Human fetal bone marrow was used to derive the MSCs.
Statistical Information
P-Value
p<0.001 for BDNF production comparison
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website